Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting ...

They are nine women from vastly different backgrounds; none is a household name, few have ever made the news, yet they are all in their own right extraordinary.

Hyaluronidase naturally degrades hyaluronic acid, leading to issues with cells that produce myelin (the protective sheath ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

"The City did not initiate moving the cell tower. The City agreed to this to accommodate the State’s intended use of the land ...

A new multiple sclerosis (MS) research project designed to help the brain repair itself by activating its own healing ...